• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

出现恶心临床症状的住院犬口服昂丹司琼后的血浆浓度。

Plasma Concentrations of Oral Ondansetron in Hospitalized Dogs Exhibiting Clinical Signs of Nausea.

作者信息

Zersen Kristin M, Molli Angela, Weisbeck Brooke G, Fedotova Samantha, Quimby Jessica M, Gustafson Daniel L, Shropshire Sarah B

机构信息

Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.

Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Vet Sci. 2024 Mar 3;11(3):112. doi: 10.3390/vetsci11030112.

DOI:10.3390/vetsci11030112
PMID:38535846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10975877/
Abstract

The purpose of this study was to evaluate plasma ondansetron (OND) concentrations in a population of dogs with naturally occurring nausea after oral OND administration. Twenty-four dogs were randomly assigned to receive one of the following doses of oral OND: 0.5 mg/kg q8h, 0.5 mg/kg q12h, 1 mg/kg q8h, or 1 mg/kg q12h. Blood samples for plasma OND measurements were collected at baseline and 2, 4, and 8 h after administration of the first dose of OND. OND concentrations averaged over an 8 h time period were not significantly different between dose groups (0.5 mg/kg group: median 8.5 ng/mL [range 1-96.8 ng/mL], 1 mg/kg group: median 7.4 ng/mL [range 1-278.7 ng/mL]). The mean maximum concentrations in the 0.5 mg/kg and 1 mg/kg groups were 35.8 ± 49.0 ng/mL and 63.3 ± 121.1 ng/mL, respectively. OND concentrations were below the lower limit of quantification (LLOQ) in 50% (18/36) of samples in the 0.5 mg/kg groups and 39% (14/36) of samples in the 1 mg/kg groups. Six dogs (6/24, 25%) did not have OND detected at any time. The mean nausea scores at baseline were similar amongst all groups and decreased over time. The bioavailability of oral OND appears to be poor. Despite low plasma OND concentrations, nausea scores improved over time.

摘要

本研究的目的是评估口服昂丹司琼(OND)后自然发生恶心的犬群体中的血浆昂丹司琼(OND)浓度。24只犬被随机分配接受以下口服OND剂量之一:0.5mg/kg每8小时一次、0.5mg/kg每12小时一次、1mg/kg每8小时一次或1mg/kg每12小时一次。在基线以及首次给予OND后2、4和8小时采集用于血浆OND测量的血样。各剂量组在8小时时间段内的OND浓度平均值无显著差异(0.5mg/kg组:中位数8.5ng/mL[范围1 - 96.8ng/mL],1mg/kg组:中位数7.4ng/mL[范围1 - 278.7ng/mL])。0.5mg/kg组和1mg/kg组的平均最大浓度分别为35.8±49.0ng/mL和63.3±121.1ng/mL。0.5mg/kg组50%(18/36)的样本和1mg/kg组39%(14/36)的样本中OND浓度低于定量下限(LLOQ)。6只犬(6/24,25%)在任何时候均未检测到OND。所有组在基线时的平均恶心评分相似且随时间下降。口服OND的生物利用度似乎较差。尽管血浆OND浓度较低,但恶心评分随时间有所改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa8/10975877/fd928f8d4d8d/vetsci-11-00112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa8/10975877/09dc9dc4c813/vetsci-11-00112-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa8/10975877/fd928f8d4d8d/vetsci-11-00112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa8/10975877/09dc9dc4c813/vetsci-11-00112-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa8/10975877/fd928f8d4d8d/vetsci-11-00112-g002.jpg

相似文献

1
Plasma Concentrations of Oral Ondansetron in Hospitalized Dogs Exhibiting Clinical Signs of Nausea.出现恶心临床症状的住院犬口服昂丹司琼后的血浆浓度。
Vet Sci. 2024 Mar 3;11(3):112. doi: 10.3390/vetsci11030112.
2
Pharmacokinetics and anti-nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea.静脉注射昂丹司琼在出现恶心临床症状的住院犬中的药代动力学和止吐效果。
J Vet Pharmacol Ther. 2022 Nov;45(6):508-515. doi: 10.1111/jvp.13087. Epub 2022 Jul 28.
3
A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.一项随机、双盲、多中心试验,比较透皮东莨菪碱加昂丹司琼与单用昂丹司琼在门诊环境中预防术后恶心和呕吐的效果。
Anesth Analg. 2009 May;108(5):1498-504. doi: 10.1213/ane.0b013e31819e431f.
4
Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy.昂丹司琼与昂丹司琼、地塞米松和氯丙嗪预防多日顺铂化疗相关恶心和呕吐的比较。
J Clin Oncol. 1993 Dec;11(12):2391-5. doi: 10.1200/JCO.1993.11.12.2391.
5
Bioequivalence of ondansetron oral soluble film 8 mg (ZUPLENZ) and ondansetron orally disintegrating tablets 8 mg (ZOFRAN) in healthy adults.8毫克昂丹司琼口腔可溶性薄膜(祖普伦)与8毫克昂丹司琼口腔崩解片(佐芬)在健康成年人中的生物等效性。
Am J Ther. 2015 Mar-Apr;22(2):90-7. doi: 10.1097/MJT.0000000000000174.
6
Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies.随机双盲交叉的昂丹司琼-地塞米松与昂丹司琼-安慰剂治疗恶性肿瘤儿科患者化疗引起的恶心和呕吐的研究
J Pediatr Hematol Oncol. 1995 May;17(2):145-50. doi: 10.1097/00043426-199505000-00008.
7
Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients. French Ondansetron Study Group.口服昂丹司琼预防乳腺癌患者化疗引起的呕吐。法国昂丹司琼研究组。
Eur J Cancer. 1995;31A(1):15-9. doi: 10.1016/0959-8049(94)00369-g.
8
[Insufficient efficacy of the use of a single 8 mg tablet of ondansetron in the prevention of nausea and vomiting induced by FEC chemotherapy].[单次使用8毫克昂丹司琼片剂预防FEC化疗引起的恶心和呕吐效果不佳]
Bull Cancer. 1995 Jan;82(1):67-9.
9
Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomiting.卡索匹坦甲磺酸酯预防顺铂致恶心呕吐的随机、双盲、剂量范围研究。
Ann Oncol. 2009 Nov;20(11):1867-73. doi: 10.1093/annonc/mdp194. Epub 2009 Jun 18.
10
Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy.在轻度和中度致吐性化疗中,使用昂丹司琼和甲泼尼龙与甲氧氯普胺和甲泼尼龙进行止吐预防。
J Pain Symptom Manage. 1999 Sep;18(3):218-22. doi: 10.1016/s0885-3924(99)00071-8.

本文引用的文献

1
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.随机、安慰剂对照试验和荟萃分析显示昂丹司琼对腹泻型肠易激综合征有益:TRITON 试验。
Aliment Pharmacol Ther. 2023 Jun;57(11):1258-1271. doi: 10.1111/apt.17426. Epub 2023 Mar 3.
2
Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.奥丹西酮治疗伴有前庭疾病的犬恶心:一项双盲、随机、安慰剂对照交叉研究。
J Vet Intern Med. 2022 Sep;36(5):1726-1732. doi: 10.1111/jvim.16504. Epub 2022 Jul 29.
3
Pharmacokinetics and anti-nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea.
静脉注射昂丹司琼在出现恶心临床症状的住院犬中的药代动力学和止吐效果。
J Vet Pharmacol Ther. 2022 Nov;45(6):508-515. doi: 10.1111/jvp.13087. Epub 2022 Jul 28.
4
The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy.血清素神经传递在胃肠道中的作用和药物治疗。
Molecules. 2022 Mar 3;27(5):1680. doi: 10.3390/molecules27051680.
5
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.氢吗啡酮、乙酰丙嗪和格隆溴铵联合预给药对健康犬术前止吐和恶心的预防作用:口服马罗皮坦和昂丹司琼的效果。
J Am Vet Med Assoc. 2021 Dec 15;260(S1):S40-S45. doi: 10.2460/javma.21.02.0082.
6
The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.奥丹司琼治疗犬前庭综合征恶心的效果。
BMC Vet Res. 2021 Jun 21;17(1):222. doi: 10.1186/s12917-021-02931-9.
7
Assessing the Efficacy of Maropitant Versus Ondansetron in the Treatment of Dogs with Parvoviral Enteritis.评估马罗匹坦与昂丹司琼治疗犬细小病毒性肠炎的疗效。
J Am Anim Hosp Assoc. 2018 Nov/Dec;54(6):338-343. doi: 10.5326/JAAHA-MS-6650. Epub 2018 Oct 1.
8
The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.马罗匹坦对犬术中异氟烷需求及术后恶心呕吐的影响:一项随机临床试验。
Vet Anaesth Analg. 2017 Jul;44(4):785-793. doi: 10.1016/j.vaa.2016.10.006. Epub 2017 Apr 12.
9
Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.昂丹司琼、马罗匹坦和胃复安在犬低剂量顺铂所致恶心和呕吐模型中的抗恶心作用及药代动力学:一项双盲交叉研究。
BMC Vet Res. 2017 Aug 16;13(1):244. doi: 10.1186/s12917-017-1156-7.
10
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.马罗匹坦与胃复安预防犬吗啡诱导的恶心和呕吐的比较。
Can Vet J. 2017 Jan;58(1):35-38.